The Asthma Control Test (ACT) as an alternative tool to Global Initiative for Asthma (GINA) guideline criteria for assessing asthma control in Vietnamese outpatients by Nguyen, V.N. et al.
Prim Care Respir J 2012; 21(1): 85-89
RESEARCH PAPER
The Asthma Control Test (ACT) as an alternative tool to
Global Initiative for Asthma (GINA) guideline criteria for
assessing asthma control in Vietnamese outpatients  
*Vinh Nhu Nguyena, Niels Chavannesb, Lan Thi Tuyet Lec, David Priced
a Family Medicine Department, University of Medicine and Pharmacy, Ho Chi Minh City, Vietnam
b Department of Public Health and Primary Care, Leiden University Medical Center, Leiden, The Netherlands
c Physiology Department, University of Medicine and Pharmacy, Ho Chi Minh City, Vietnam
d Centre of Academic Primary Care, University of Aberdeen, Aberdeen, UK
Received 12th June 2011; resubmitted 19th August 2011; revised 7th September 2011; accepted 9th September 2011; online 26th October 2011
Abstract
Aims: To determine the reliability and validity of the Asthma Control Test (ACT) to detect Global Initiative for Asthma (GINA)-defined
uncontrolled or partly controlled asthma, and to determine the agreement between ACT and GINA in classifying asthma control among
Vietnamese patients. 
Methods: A cross-sectional study was performed in 323 of 360 invited outpatients with asthma in Ho Chi Minh City to compare the ACT
and GINA classification for asthma control.    
Results: Internal consistency of the ACT (Cronbach’s alpha) was 0.83. The kappa coefficient of 0.55, based on the ternary split, represents
moderate agreement between the two rating systems with a correctly classified rate of 75%. The area under the receiver operating
characteristics curve for the ACT score predicting GINA control was 0.85. To detect GINA-defined ‘not controlled asthma’, the ACT had a
sensitivity of 70%, specificity of 93%, and a positive predictive value of 89%, with a cut-off point of 19. The validity of the ACT with
regard to agreement with the GINA classification was consistent across both sexes, but less so in adolescents or younger adults. The ACT
score was significantly correlated with the percentage predicted forced expiratory volume in 1 second (r=0.35, p<0.001) and percentage
predicted peak expiratory flow (r=0.26, p<0.001).
Conclusions: The Vietnamese ACT is useful for identifying outpatients with GINA-defined uncontrolled or partly controlled asthma.
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Introduction 
The prevalence of asthma in Vietnam is estimated to be 5% in
adults.1 Although asthma is not curable it is treatable, and the
best way to reduce the burden of disease is to control it. Current
Global Initiative for Asthma (GINA) guidelines emphasise the
need to evaluate asthma control to guide asthma management
decisions.2 Guideline-defined asthma control can be achieved
and maintained for the majority of patients in controlled trial
settings.3–5 In Vietnam, the GINA guidelines were recently used
as the main reference source for the national asthma guidelines.1
A recent study suggested that the level of asthma control in
Vietnam is poorer than expected, with less than 1% of patients
studied meeting the definition of asthma control.6 Apart from
the lack of preventive medications, limited access to asthma
control assessment is another factor responsible for this poor
level of asthma control. It is difficult to follow GINA criteria to
evaluate asthma control because of the lack of access to lung
function assessment. A simple, applicable, and accessible but
validated tool to assess asthma control is therefore urgently
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needed for patients with asthma in Vietnam. The Asthma
Control Test (ACT) questionnaire – a simple, self-administered,
and rapidly completed assessment tool – might be appropriate
to meet this demand.7–9 The ACT has the added advantages that
it does not require lung function assessments and can be applied
at all levels of healthcare.7,10 However, this tool has not been
validated as a reliable predictor of GINA-defined asthma control
in Vietnam. A study was therefore undertaken to validate the
Vietnamese version of the ACT.
Methods 
This was a prospective study recruiting ambulatory patients aged
>12 years with asthma at the University Medical Centre, Ho Chi
Minh City, Vietnam between January 2008 and January 2009.
The objective was to determine the reliability and validity of the
ACT as a means of detecting GINA-defined uncontrolled and
partly controlled asthma (together labelled ‘not-controlled
asthma’ according to GINA). The study also set out to determine
the reliability and validity of the agreement between ACT and
GINA in classifying asthma control, as well as to determine the
consistency across age, gender, and asthma severity subgroups.  
Patients who satisfied the inclusion criteria (>12 years old,
asthma diagnosed according to GINA in the past 6 months,
literate in Vietnamese, and able to perform spirometry) were
included in the study. Subjects were excluded if they had any of
the following exclusion criteria: hospitalised for asthma or had
an acute upper or lower respiratory tract infection within 4
weeks prior to study; had a known respiratory disorder other
than asthma and/or systemic/thoracic abnormalities that
influence normal lung function; or had smoked >10 pack-years.
All eligible patients had to provide informed consent before
being entered into the study.
The questionnaire used was the ACT Vietnamese version for
adults, downloaded from www.asthmacontroltest.com with
user approval obtained from the authorised owner.
With a presumption based on the literature that the ACT can
detect GINA-defined ‘not-controlled asthma’ with a sensitivity of
70% and a specificity of 75%,7,8 the calculated sample size was
323 subjects.
Eligible patients answered and submitted the ACT
questionnaire to the investigators before physician assessment.
Patients then performed spirometry tests followed by interviews
with a pulmonologist who evaluated their asthma control and
provided treatment modifications as required.
A cognitive debriefing was performed with 20 patients before
conducting an official debriefing. The modified questionnaire was
re-tested with 10 other asthmatic patients. The final version of the
questionnaire was then used for this research.
Data analysis  
SPSS Version 16.0 software was used to analyse the data and a
p value of <0.05 was considered statistically significant.
Cronbach’s alpha was used to determine the internal reliability of
the five items of the questionnaire.  
The validity of the ACT as a means of detecting GINA-
defined ‘not-controlled asthma’ using the GINA binary split
criterion as the gold standard (‘not-controlled’ being combined
uncontrolled and partly controlled asthma versus controlled
asthma) was determined by sensitivity, specificity, positive and
negative predictive values (PPV and NPV), likelihood ratios (LR),
the correctly classified rate and area under the ROC curve (AUC).
In the ternary split of GINA-defined asthma control, the
agreement between GINA rating (uncontrolled, partly controlled
and controlled asthma) and ACT rating (ACT score <15, 15–19
and 20–25) in the classification of asthma control was
determined using the kappa coefficient of agreement and
correctly classified rates.
Subgroup analyses were undertaken based on asthma
severity, gender, and age to explore the consistency of the validity
of the ACT and its agreement with GINA across the subgroups.
Spearman’s coefficient between the ACT and three levels of
treatment modifications, as well as ANOVA testing to assess the
differences in mean ACT scores among these levels, were applied.
The relationship between ACT and the percentage of forced
expiratory volume in 1 second (%FEV1) compared with the
predicted value, and between ACT and the percentage of peak
expiratory flow (%PEF) compared with the predicted value, was
determined by Pearson correlation coefficients (r).
Results
Revision of the questionnaire 
The cognitive debriefing showed that most patients understood
four of the five questions. However, the fourth question caused
confusion as it asked about rescue medication usage but some
patients answered about preventive medication. The question
was then revised by rewording as ‘rescue medication’ and giving
a brief explanation of what these medications actually are, citing
examples such as salbutamol and Ventolin which are known and
commonly used in Vietnam. The revised version questionnaire
then underwent further cognitive debriefing, resulting in no
residual confusion. 
Characteristics of study patients 
A total of 360 patients were invited to participate in the study;
323 (90%) of mean age 36 years (range 12–80) agreed to
participate. Females comprised 57% of the participants with a
mean percentage predicted FEV1 and PEF of 86% and 88.6%,
respectively, and a mean ACT score of 20.5. Other characteristics
are described in Table 1, in which GINA stage 3 is prominent
(28%), but in general the patients were equally distributed
among the four stages. Most of the patients were using
preventive medication; the majority had controlled asthma
according to both GINA and ACT criteria and were continued on
the same treatment after their visit.
Reliability and empirical validity of the ACT
Cronbach’s alpha was 0.83, indicating a high consistency among
the answers to the five questions of the ACT questionnaire. 
The cut-off point for the ACT in detecting GINA ‘not-
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controlled asthma’ was 19, which yielded the largest AUC of
0.85 with a sensitivity of 70%, specificity of 73%, PPV of 89%,
NPV of 79%, positive LR of 9.6, negative LR of 0.3, and a
correctly classified rate of 83%. These characteristics indicate a
good screening tool. The consistency of these findings was
maintained across subgroups of patients based on gender, age,
and asthma severity (see Appendix 1 available online at
www.thepcrj.org).
Agreement between ACT and GINA in classifying three
levels of asthma control 
The kappa value was 0.55 (Table 2), indicating a moderate level
of agreement beyond chance between the two rating systems
(Î=0.4–0.6).11,12 Both rating systems correctly classified 75% at
three levels of asthma control.
In subgroup analyses (see Appendix 2 available online at
www.thepcrj.org), the kappa coefficient and correctly classified
rates were worse in patients with stage 4 asthma than in those with
other stages. These two parameters were, however, similar in
patients with mild asthma (stages 1 and 2) and in those with
moderate to severe asthma (stages 3 and 4), and in females
compared with males. On the other hand, the kappa coefficient
indicated only fair agreement in adolescents (0.2<κ=0.39<0.4) with
a correctly classified rate of 69%, which is worse than in adults who
had a kappa of 0.58 and a correctly classified rate of 76%.
Responsiveness of the ACT to specialist treatment
modification 
The ACT scores for groups receiving different asthma treatment
decisions after medical assessment are shown in Table 3. The
mean ACT score was similar for those in whom treatment was
either maintained or stepped down (p=0.9) but much lower in
those in whom treatment was stepped up. There was a
significant correlation between the ACT score and asthma
treatment modification (Spearman’s r=–0.36, p<0.001).
Relationship between ACT score and %FEV1 and %PEF 
The Pearson coefficient between the ACT score and %FEV1 was
0.35 (p<0.001) and between the ACT score and %PEF it was
0.26 (p<0.001). 
Discussion 
Achieving and maintaining asthma control are fundamental
elements of asthma management.2 Practical tools are needed to
assess asthma control in asthma management. Most tools used
to evaluate asthma control consider airflow obstruction as a
criterion. However, this is often very difficult to perform in
developing countries such as Vietnam because spirometers and
peak flow meters are not readily available. A tool is required that
measures the multidimensional nature of asthma control and that
is easy and quick to administer and interpret in order to facilitate
the assessment of asthma control in clinical practice. The ACT has
proved to be a valid tool for this purpose in other settings.7–9
Main findings, and interpretation in relation to
previously published work 
This is the first evaluation of the ACT undertaken in Vietnam. It
was found to be able to predict GINA-defined ‘not-controlled
asthma’ (positive LR 9.6, PPV 89%) with a sensitivity of 70% and
a specificity of 93%. The sensitivity is similar to studies from
No %
Asthma severity according GINA
Stage 1 71 22
Stage 2 82 25
Stage 3 90 28
Stage 4 80 25
Preventive medication use before visit
No preventive drugs 14 4.3
Inhaled corticosteroid (ICS) 65 20.1








Partly controlled 84 26
Controlled 208 64.4
Treatment modification
Maintain current treatment 133 41.2
Step up 72 22.3
Step down 118 36.5
ACT=Asthma Control Test; GINA=Global Initiative for Asthma.
Table 1. Characteristics of study patients
GINA             GINA-defined control Total
Uncontrolled Partly Controlled n (%)
n (%) controlled n (%)
ACT n (%)
ACT <15 27 (8.4) 4 (1.2) 0 (0) 31 (9.6)
(uncontrolled)
ACT 15–19 21 (6.5) 50 (15.5) 13 (4.0) 84 (26.0)
(partly controlled)
ACT >20 0 (0) 43 13.3) 165 (51.1) 208 (64.4)
(controlled)
Total n (%) 48 (14.9) 97 (30.0) 178 (55.1) 323 (100)
Kappa=0.55, p<0.001, correctly classified rate=75%
ACT=Asthma Control Test; GINA=Global Initiative for Asthma.
Table 2. Agreement between GINA classification and
ACT classification of asthma control
Treatment modification Total
Stepping Maintaining  Stepping (n=323)
down (n=133) up
(n=118) (n=72)
Mean ACT score 21.6 21.6 16.6 20.5
p<0.001 (ANOVA test)
Table 3. Difference in mean Asthma Control Test (ACT)
score across three categories of treatment modification
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America (69–71%)7,9 and Hong Kong (70.5%),13 but lower than
figures reported in China (80%)14 and Korea (85%).15 The
specificity is similar to a study from Korea (93%),15 and reached
a higher level than in some other countries.7,9,13,14,16 With a cut-off
point of <19, the ACT correctly predicted GINA-defined ‘not-
controlled asthma’ in 89% of cases while an ACT score of >20
predicted GINA-defined controlled asthma in 79% of cases. The
area under the ROC curve (AUC) was acceptable at 0.85 (95%
CI 0.80 to 0.88) and of similar magnitude to previous findings for
the ACT.7,14,17–20 The ACT has been shown to be a reliable tool by
previous authors,7,8,14–17,21,22 and this is confirmed by this study in a
Vietnamese outpatient setting in which Cronbach’s alpha
reached 0.83, indicating a high consistency among the answers
to the five questions.  
Most patients in this study population were using preventive
medications (Table 1). These numbers are much higher than
those in other studies (6–13.6%),23,24 including a Vietnamese
subgroup in an international study.23 This may explain why the
number of patients with severe asthma in this study is higher
than in some other studies,23,25–28 while the rate of patients with
controlled asthma in this study is also higher than that in other
studies.23,26,28 This result supports the concept that severity may
not be an important index in asthma management.2 It is clear
that 53% of patients in this study had moderate to severe
asthma, but their asthma control is good because of their use of
preventer therapy. On the other hand, the proportion of patients
with moderate to severe asthma in some other studies is low
and the rate of asthma control is also quite low,23,25,27,28 which
may be due to lack of appropriate therapy or a poor response to
such therapy.
In this study a maximum ACT score of 25 indicates
controlled asthma; 94.7% of those with an ACT score of 25 had
controlled asthma, 5.3% had partly controlled asthma and none
had uncontrolled asthma according to the GINA definition. In
addition, patients who responded with the maximum 5 points
for the fifth question (indicating their asthma is completely
controlled) can be relied upon in our study population. Seventy-
three patients in this study responded with 5 points for the fifth
question, of whom 83.6% had controlled asthma, 16.4% had
partly controlled asthma, and 0% had uncontrolled asthma
according to the GINA definition. This suggests that, in patients
who rated 5 points for the fifth ACT question or had an ACT
total score of 25, none had GINA-defined uncontrolled asthma.
The kappa level of agreement between the two systems was
0.55, representing moderate agreement between the two
rating systems,11 while the correctly classified rate was 75%.
Another positive finding in this study was no extreme difference
in classification of asthma control between the two rating
systems: no patient had an ACT score of >20 while having
GINA-defined uncontrolled asthma and no patient with GINA-
defined controlled asthma had an ACT score of <15 (Table 2).
The subgroup analyses (Appendices 1 and 2) showed that
the value of the ACT in detecting GINA-defined ‘not-controlled
asthma’ and the agreement between the ACT and GINA in
classifying asthma control was similar in both sexes and groups
of patients who had mild asthma (stages 1 and 2) to those who
had moderate to severe asthma (stages 3 and 4). The correctly
classified rate in assessing asthma control of the two rating
systems (GINA and ACT) (both two-level and three-level
classification) was worse in patients with stage 4 asthma (75%
and 69%, respectively). The validity of the ACT in adolescents is
worse than in adults with regard to all test parameters except
specificity. The same was found when comparing the younger
age group with the older age group. This may be because
adolescents and younger adults pay less attention to their
health, resulting in recall bias during the completion of the
questionnaire. This was confirmed again by the kappa
agreement coefficients and the correctly classified rates of
adolescents and younger groups, which were poorer than those
in older age groups.
Some studies state that the ACT is poorly correlated with
FEV117 or suggest that it correlates better with PEF than with
FEV1,29 but the present study found the opposite. The ACT total
score was correlated with %FEV1 (r=0.35, p<0.001) and this
correlation was better than the correlation between the ACT
and %PEF (r=0.26, p<0.001). 
The mean ACT score of those who were stepped up (16.6)
was significantly lower than the mean score of those who were
stepped down (21.6) and those who were maintained on
treatment (21.6) (p<0.001, Table 3). This suggests that ACT can
usefully predict patients who need increased treatment due to
poor asthma control. This is important in clinical practice because
these patients need to have their treatment reviewed as well as
addressing risk factors for poor asthma control.30 A study of 382
patients in Hong Kong found that the ACT could predict step-up
of asthma therapy in 70.2% of consultations,13 suggesting that
this tool could actually assist doctors’ treatment decisions.
Indeed, Ko et al. found that the ACT correlates better with
treatment decisions made by asthma specialists than spirometry,
PEF, or fractional exhaled nitric oxide measurements.13
Limitations of the study 
This study has several limitations, including the possibility of
patient selection bias as participants represent a convenience
sample from a teaching hospital which may not be
representative of the overall population of outpatients with
asthma in Vietnam. Patients’ recall of asthma symptoms may
not be entirely accurate and we cannot rule out recall bias on
the part of participating patients. Another limitation is choosing
the GINA 2006 classification of asthma control as the gold
standard assessment of asthma control. However, there is no
real gold standard for measuring asthma control; even the GINA
classifications are described as a ‘working scheme based on
current opinion which has not been validated’.2
In spite of these limitations, the study provides evidence that
the Vietnamese ACT is a reliable tool to assess asthma control and,
with a cut-off point of 19, it can predict GINA-defined ‘not-
Copyright PCRS-UK - reproduction prohibited
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controlled asthma’ with a high PPV and a high positive LR. It
appears to be a good tool to predict GINA-defined ‘not-controlled
asthma’ and can predict the step-up decision of doctors.
Conclusions   
The ACT is a reliable and simple tool that does not require
spirometry measurements. This might be a significant asset in
the management of outpatients with asthma in Vietnam. The
questionnaire score correlates well with treatment modifications
and lung function parameters (FEV1 and PEF). The ACT is easily
and quickly completed by patients and can serve as a useful tool
in everyday practice to guide adjustments in asthma therapy.  
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Appendix 1: Sensitivity, specificity, predictive values, likelihood ratios, correctly classified rate and AUC of the ACT in
subgroups of patients
N % Cut-off Sn Sp (+)PV (-)PV (+)LR (-)LR Correctly AUC
point classified
Subgroups of asthma severity
Stage 1 71 22 19 59 100 100 85 - 0.4 87 0.87
Stage 2 82 25 19 78 90 83 86 7.8 0.2 85 0.84
Stage 3 90 28 19 78 90 91 77 7.8 0.2 83 0.87
Stage 4 80 25 19 61 90 86 67 5.9 0.4 75 0.81
Stages 1&2 153 47 19 70 95 88 85 13.9 0.3 86 0.85
Stages 3&4 170 53 19 70 90 89 72 6.9 0.3 79 0.84
Subgroups of gender
Female 138 43 19 72 92 89 79 8.9 0.3 83 0.86
Male 185 57 19 67 93 89 80 10.8 0.3 83 0.82
Subgroups of age
12–18 62 19 19 50 92 81 72 6.0 0.6 74 0.74
19–80 261 81 19 74 93 90 80 10.6 0.3 85 0.87
12–35 164 51 19 62 90 82 77 6.6 0.4 79 0.81
36–80 159 49 19 78 95 94 82 16 0.2 87 0.87
ACT=Asthma Control Test; AUC=area under the curve; LR, likelihood ratio; PV=predictive value; Sn=sensitivity; Sp=specificity.
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Appendix 2: Agreement and correctly classified rate of GINA and ACT in classifying asthma control in subgroups of
patients
N % kappa p value Correctly classified
Subgroups of asthma severity
Stage 1 71 22 0.57 <0.001 83%
Stage 2 82 25 0.53 <0.001 76%
Stage 3 90 28 0.56 <0.001 73%
Stage 4 80 25 0.48 <0.001 69%
Stages 1 and 2 153 47 0.55 <0.001 79%
Stages 3 and 4 170 53 0.53 <0.001 71%
Subgroups of gender
Female 138 43 0.56 <0.001 75%
Male 185 57 0.53 <0.001 75%
Subgroups of age
12–18 62 19 0.39 <0.001 69%
19–80 261 81 0.58 <0.001 76%
12–35 164 51 0.46 <0.001 73%
36–80 159 49 0.61 <0.001 77%
ACT=Asthma Control Test; GINA=Global Initiative for Asthma.
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